• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SAGE Therapeutics downgraded by RBC Capital Mkts with a new price target

    10/4/24 7:46:56 AM ET
    $SAGE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $SAGE alert in real time by email
    RBC Capital Mkts downgraded SAGE Therapeutics from Outperform to Sector Perform and set a new price target of $4.00 from $10.00 previously
    Get the next $SAGE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SAGE

    DatePrice TargetRatingAnalyst
    3/11/2025$5.00Underperform
    BofA Securities
    11/21/2024$4.00Underperform → Sector Perform
    RBC Capital Mkts
    10/10/2024Mkt Perform
    Raymond James
    10/4/2024$10.00 → $4.00Outperform → Sector Perform
    RBC Capital Mkts
    7/30/2024$16.00 → $10.00Buy → Hold
    TD Cowen
    7/25/2024$18.00 → $12.00Overweight → Neutral
    JP Morgan
    5/29/2024$15.00Neutral
    Robert W. Baird
    5/29/2024$8.00Sell
    Citigroup
    More analyst ratings

    $SAGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Germano Geno J

      4 - Sage Therapeutics, Inc. (0001597553) (Issuer)

      6/13/25 4:14:14 PM ET
      $SAGE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Golumbeski George

      4 - Sage Therapeutics, Inc. (0001597553) (Issuer)

      6/13/25 4:14:04 PM ET
      $SAGE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Frates James M

      4 - Sage Therapeutics, Inc. (0001597553) (Issuer)

      6/13/25 4:13:57 PM ET
      $SAGE
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $SAGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities resumed coverage on SAGE Therapeutics with a new price target

      BofA Securities resumed coverage of SAGE Therapeutics with a rating of Underperform and set a new price target of $5.00

      3/11/25 7:43:31 AM ET
      $SAGE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SAGE Therapeutics upgraded by RBC Capital Mkts with a new price target

      RBC Capital Mkts upgraded SAGE Therapeutics from Underperform to Sector Perform and set a new price target of $4.00

      11/21/24 7:42:56 AM ET
      $SAGE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Raymond James resumed coverage on SAGE Therapeutics

      Raymond James resumed coverage of SAGE Therapeutics with a rating of Mkt Perform

      10/10/24 8:30:27 AM ET
      $SAGE
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $SAGE
    SEC Filings

    See more
    • SEC Form SC TO-C filed by Sage Therapeutics Inc.

      SC TO-C - Sage Therapeutics, Inc. (0001597553) (Subject)

      6/16/25 5:26:56 PM ET
      $SAGE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC14D9C filed by Sage Therapeutics Inc.

      SC14D9C - Sage Therapeutics, Inc. (0001597553) (Subject)

      6/16/25 5:20:11 PM ET
      $SAGE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC TO-C filed by Sage Therapeutics Inc.

      SC TO-C - Sage Therapeutics, Inc. (0001597553) (Subject)

      6/16/25 11:40:45 AM ET
      $SAGE
      Biotechnology: Pharmaceutical Preparations
      Health Care